Matches in SemOpenAlex for { <https://semopenalex.org/work/W2142596869> ?p ?o ?g. }
- W2142596869 endingPage "310" @default.
- W2142596869 startingPage "269" @default.
- W2142596869 abstract "Human narcolepsy is a chronic sleep disorder affecting 1:2000 individuals. The disease is characterized by excessive daytime sleepiness, cataplexy and other abnormal manifestations of REM sleep, such as sleep paralysis and hypnagogic hallucinations. Recently, it was discovered that the pathophysiology of (idiopathic) narcolepsy-cataplexy is linked to hypocretin ligand deficiency in the brain and cerebrospinal fluid (CSF), as well as the positivity of the human leukocyte antigen (HLA) DR2/DQ6 (DQB1*0602). The symptoms of narcolepsy can also occur during the course of other neurological conditions (i.e. symptomatic narcolepsy). We define symptomatic narcolepsy as those cases that meet the International Sleep Disorders Narcolepsy Criteria, and which are also associated with a significant underlying neurological disorder that accounts for excessive daytime sleepiness (EDS) and temporal associations. To date, we have counted 116 symptomatic cases of narcolepsy reported in literature. As, several authors previously reported, inherited disorders (n=38), tumors (n=33), and head trauma (n=19) are the three most frequent causes for symptomatic narcolepsy. Of the 116 cases, 10 are associated with multiple sclerosis, one case of acute disseminated encephalomyelitis, and relatively rare cases were reported with vascular disorders (n=6), encephalitis (n=4) and degeneration (n=1), and hererodegenerative disorder (three cases in a family). EDS without cataplexy or any REM sleep abnormalities is also often associated with these neurological conditions, and defined as symptomatic cases of EDS. Although it is difficult to rule out the comorbidity of idiopathic narcolepsy in some cases, review of the literature reveals numerous unquestionable cases of symptomatic narcolepsy. These include cases with HLA negative and/or late onset, and cases in which the occurrences of the narcoleptic symptoms are parallel with the rise and fall of the causative disease. A review of these cases (especially those with brain tumors), illustrates a clear picture that the hypothalamus is most often involved. Several cases of symptomatic cataplexy (without EDS) were also reported and in contrast, these cases appear to be often associated with non-hypothalamic structures. CSF hypocretin-1 measurement were also carried out in a limited number of symptomatic cases of narcolepsy/EDS, including narcolepsy/EDS associated with tumors (n=5), head trauma (n=3), vascular disorders (n=5), encephalopathies (n=3), degeneration (n=30), demyelinating disorder (n=7), genetic/congenital disorders (n=11) and others (n=2). Reduced CSF hypocretin-1 levels were seen in most symptomatic narcolepsy cases of EDS with various etiologies and EDS in these cases is sometimes reversible with an improvement of the causative neurological disorder and an improvement of the hypocretin status. It is also noted that some symptomatic EDS cases (with Parkinson diseases and the thalamic infarction) appeared, but they are not linked with hypocretin ligand deficiency. In contrast to idiopathic narcolepsy cases, an occurrence of cataplexy is not tightly associated with hypocretin ligand deficiency in symptomatic cases. Since CSF hypocretin measures are still experimental, cases with sleep abnormalities/cataplexy are habitually selected for CSF hypocretin measures. Therefore, it is still not known whether all or a large majority of cases with low CSF hypocretin-1 levels with CNS interventions, exhibit EDS/cataplexy. It appears that further studies of the involvement of the hypocretin system in symptomatic narcolepsy and EDS are helpful to understand the pathophysiological mechanisms for the occurrence of EDS and cataplexy." @default.
- W2142596869 created "2016-06-24" @default.
- W2142596869 creator A5060824249 @default.
- W2142596869 creator A5089057313 @default.
- W2142596869 date "2005-08-01" @default.
- W2142596869 modified "2023-10-11" @default.
- W2142596869 title "Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system" @default.
- W2142596869 cites W142147795 @default.
- W2142596869 cites W1519232679 @default.
- W2142596869 cites W1544707811 @default.
- W2142596869 cites W1593151160 @default.
- W2142596869 cites W1597355886 @default.
- W2142596869 cites W1599998676 @default.
- W2142596869 cites W167596909 @default.
- W2142596869 cites W1964502071 @default.
- W2142596869 cites W1965465390 @default.
- W2142596869 cites W1966677975 @default.
- W2142596869 cites W1967884630 @default.
- W2142596869 cites W1968498375 @default.
- W2142596869 cites W1968944348 @default.
- W2142596869 cites W1968974329 @default.
- W2142596869 cites W1970813526 @default.
- W2142596869 cites W1977083279 @default.
- W2142596869 cites W1977279472 @default.
- W2142596869 cites W1978871425 @default.
- W2142596869 cites W1980648981 @default.
- W2142596869 cites W1982413389 @default.
- W2142596869 cites W1982627737 @default.
- W2142596869 cites W1983298714 @default.
- W2142596869 cites W1985359386 @default.
- W2142596869 cites W1985685635 @default.
- W2142596869 cites W1985692037 @default.
- W2142596869 cites W1987664300 @default.
- W2142596869 cites W1990481399 @default.
- W2142596869 cites W1993468172 @default.
- W2142596869 cites W1995216846 @default.
- W2142596869 cites W1998101177 @default.
- W2142596869 cites W2001313819 @default.
- W2142596869 cites W2001493550 @default.
- W2142596869 cites W2009016203 @default.
- W2142596869 cites W2010685764 @default.
- W2142596869 cites W2011070930 @default.
- W2142596869 cites W2012430463 @default.
- W2142596869 cites W2015126312 @default.
- W2142596869 cites W2015127187 @default.
- W2142596869 cites W2015293791 @default.
- W2142596869 cites W2016192465 @default.
- W2142596869 cites W2016583592 @default.
- W2142596869 cites W2018384802 @default.
- W2142596869 cites W2018413219 @default.
- W2142596869 cites W2022991115 @default.
- W2142596869 cites W2027740042 @default.
- W2142596869 cites W2029582941 @default.
- W2142596869 cites W2030448085 @default.
- W2142596869 cites W2035265275 @default.
- W2142596869 cites W2036163096 @default.
- W2142596869 cites W2037713617 @default.
- W2142596869 cites W2038580970 @default.
- W2142596869 cites W2041649541 @default.
- W2142596869 cites W2042212546 @default.
- W2142596869 cites W2042457228 @default.
- W2142596869 cites W2042968508 @default.
- W2142596869 cites W2043838679 @default.
- W2142596869 cites W2046082951 @default.
- W2142596869 cites W2046134526 @default.
- W2142596869 cites W2049088920 @default.
- W2142596869 cites W2049134883 @default.
- W2142596869 cites W2052039263 @default.
- W2142596869 cites W2054088581 @default.
- W2142596869 cites W2056359336 @default.
- W2142596869 cites W2059280611 @default.
- W2142596869 cites W2066212334 @default.
- W2142596869 cites W2066631210 @default.
- W2142596869 cites W2068370751 @default.
- W2142596869 cites W2068681030 @default.
- W2142596869 cites W2071454669 @default.
- W2142596869 cites W2071482417 @default.
- W2142596869 cites W2072154498 @default.
- W2142596869 cites W2074216166 @default.
- W2142596869 cites W2074847803 @default.
- W2142596869 cites W2075411602 @default.
- W2142596869 cites W2080647788 @default.
- W2142596869 cites W2081407555 @default.
- W2142596869 cites W2082491583 @default.
- W2142596869 cites W2083054300 @default.
- W2142596869 cites W2083659771 @default.
- W2142596869 cites W2086112856 @default.
- W2142596869 cites W2089248956 @default.
- W2142596869 cites W2091247005 @default.
- W2142596869 cites W2091701485 @default.
- W2142596869 cites W2092906065 @default.
- W2142596869 cites W2094180593 @default.
- W2142596869 cites W2098247793 @default.
- W2142596869 cites W2102268983 @default.
- W2142596869 cites W2107196385 @default.
- W2142596869 cites W2112607008 @default.
- W2142596869 cites W2113413798 @default.
- W2142596869 cites W2120736789 @default.